Docoh
Loading...

223 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2003 Q2
PRPO Precipio Inc
11 Aug 03
Quarterly report
8:00pm
31, 2002, the Company’s deferred tax assets were offset by a valuation allowance of approximately $26.4 million and $23.2 million, respectively, due … in Europe and the Far East offset by lower sales volumes to our North American customer base. Sales of WAVE-related consumable products increased
10-Q
2006 Q3
PRPO Precipio Inc
13 Nov 06
Quarterly report
7:00pm
in states, foreign countries and other local jurisdictions offset by refunds received. While the Company has significant net operating loss carryforwards … totaled $43,450 and $42,561, respectively, that were fully offset by valuation allowances. H. EMPLOYEE BENEFIT PLAN The Company maintains
10-Q
2006 Q2
PRPO Precipio Inc
13 Aug 06
Quarterly report
8:00pm
during the three and six months ended June 30, 2006 and 2005 relates to income taxes in states, foreign countries and other local jurisdictions offset … , 2005, deferred tax assets totaled $42,837 and $42,561, respectively, that were fully offset by valuation allowances. TRANSGENOMIC, INC
10-Q
2019 Q2
PRPO Precipio Inc
9 Aug 19
Quarterly report
2:55pm
million at the date of issuance and were recorded as a liability with an offset to debt discount. Pursuant to a letter agreement, dated as of April 20 … was recorded as a debt discount with an offset to additional paid in capital at the note issuance date. The Company reviewed the redemption features
10-Q
2019 Q3
PRPO Precipio Inc
13 Nov 19
Quarterly report
4:33pm
and were recorded as a liability with an offset to debt discount. The April 2018 Investors received 196,334 warrants to purchase shares of common stock … million at the date of issuance and were recorded as a liability with an offset to debt discount. See Note 9 – Fair Value for further discussion
8-K
EX-99.1
t874g37si 7q5hv1g0
14 Apr 15
Transgenomic Provides Financial and Business Update
8:00pm
10-Q
975z90wh4rjumnja7
13 Nov 05
Quarterly report
7:00pm
10-Q
a0691 j5h1shc9suil
14 Aug 05
Quarterly report
8:00pm
10-Q
ut7u4ghyy7 77ea4l
13 Aug 20
Quarterly report
3:07pm
8-K
EX-99.1
0kwrl6x3c frl
5 Nov 13
Transgenomic Reports Third Quarter 2013 Financial Results
7:00pm
10-Q
a75zht
5 May 10
Quarterly report
8:00pm
10-Q
xiy la0ds
13 Nov 20
Quarterly report
4:01pm
10-Q
uh3jruu0f1
13 Nov 03
Quarterly report
7:00pm
10-K
78v60gpa
27 Mar 20
Annual report
3:47pm
10-Q
xd3zvb n7wt
25 May 05
Quarterly report
8:00pm
10-Q
r4i7vv2f
4 Nov 09
Quarterly report
7:00pm
10-Q
9zqkxsnsmz
12 May 11
Quarterly report
8:00pm
10-Q
swm5hx963bpn47tme8sc
14 Nov 04
Quarterly report
7:00pm
10-Q/A
rc5p4lp8a2reof7sg
29 Jun 05
Quarterly report (amended)
8:00pm
10-Q
3xz slif28q
16 May 19
Quarterly report
4:02pm